Source - LSE Regulatory
RNS Number : 8191T
Symphony Environmental Tech. PLC
23 July 2020




The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this information is considered to be in the public domain


23 July 2020


("Symphony", the "Company" or the "Group")


Positive Bovine Coronavirus Test Results


Symphony Environmental Technologies Plc (AIM: SYM), is pleased to announce positive antiviral test results from Eurofins Laboratories for its d2p antimicrobial masterbatch technology.


Eurofins tested Symphony's d2p "Viricidal Activity Agent" incorporated in a polyolefin film, against Bovine Coronavirus in accordance with International Standard, ISO 21702-2019, and found a virus reduction of 99.84% in 24 hours. The official report is due soon, after completion of quality control checks, but Eurofins has advised Symphony that these positive results are not expected to change. The Bovine Coronavirus is a close Beta Coronavirus surrogate for COVID-19.


Michael Laurier CEO said: "this is a very exciting and positive development for our global sales team to bring to the market as quickly as possible and we look forward to receiving Eurofins final report in due course. In the challenging times that we live in today, we believe that a wide range of products from plastic packaging to Personal Protective Equipment, made with our d2p masterbatch technology will provide an extra level of protection against many different types of bacteria and fungi, and now Bovine Coronavirus.  As d2p is embedded in the plastic it will not wear off and will last for the lifetime of the plastic product. This welcome and important news comes in addition to the approval by the FDA in the United States in February of our d2p antibacterial technology for bread packaging."




Symphony Environmental Technologies Plc


Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO




Zeus Capital Limited (Nominated Adviser and Joint Broker)


Nick Cowles / David Foreman / Kieran Russell (Corporate Finance)

Tel: +44 (0) 161 831 1512

Dominic King / Victoria Ayton (Sales)

Tel: +44 (0) 203 829 5000



Hybridan LLP (Joint Broker)

Claire Louise Noyce



Tel: +44 (0) 203 764 2341

The person responsible for arranging the release of this information is Michael Laurier, CEO of the Company.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.